Thirteen new diterpenoids were discovered in Rhododendron molle flowers extract. These compounds showed significant analgesic activities, with some exhibiting stronger effects than morphine, suggesting potential for designing new pain medications.
Rhodojaponin VI is a potential treatment for neuropathic pain. It targets NSF, which regulates Cav2.2 channels and reverses their effect, offering a new class of analgesic products.
Researchers investigated the use of RJ-III, a bioactive compound found in a plant, in a drug delivery system to improve its release and pain-relieving effects.
The researchers studied grayanoids, diterpenoids found in certain plants, commonly used to treat abdominal pain, headaches, and arthritis.